Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds
1 other identifier
interventional
163
1 country
1
Brief Summary
This is a study comparing two methods of dressing a post operative wound that are currently in practice. One method is a traditional dry gauze dressing. The other method is using a negative pressure dressing that provides gentle suction on the wound. The investigators will attempt to determine how well the use of post-operative negative pressure dressing reduces wound healing problems in patients who have surgery after radiation for a sarcoma in the thigh or leg.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2015
CompletedFirst Submitted
Initial submission to the registry
December 15, 2015
CompletedFirst Posted
Study publicly available on registry
December 23, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2024
CompletedResults Posted
Study results publicly available
August 7, 2025
CompletedAugust 7, 2025
July 1, 2025
8.6 years
December 15, 2015
July 2, 2025
July 22, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Wound Complication Rate
To estimate the wound complication rate of post-operative negative pressure dressings and traditional dry dressings, and risk of secondary interventions after resection of soft tissue sarcoma in lower extremities that have received pre-operative radiation. Post-operative pain severity assessed by Visual analogue scale at 2 weeks and 6 months post-operatively where visual analogue scale ranges from zero to ten where (0 = no pain, 10 = maximum pain imaginable).
longitudinally up to 6 months postoperatively
Study Arms (2)
NPWT dressing
EXPERIMENTALStandard dry gauze dressing
PLACEBO COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Age\>18
- Willing to consent to randomization and able to participate in the study
- Lower extremity soft tissue sarcoma necessitating radiation prior to surgical resection
- Primary closure of wound
- Patients scheduled for surgical resection
You may not qualify if:
- Flap coverage or skin graft
- Patients scheduled for amputations as local control of their tumor
- Sarcomas where radiation is not planned preoperatively
- Repeat surgeries for oncologic reasons (positive margins)
- Known allergy to adhesive tape
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical University of South Carolinalead
- 3Mcollaborator
Study Sites (1)
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Leddy
- Organization
- Medical University of South Carolina
Study Officials
- PRINCIPAL INVESTIGATOR
Lee R Leddy, MD
Medical University of South Carolins
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 15, 2015
First Posted
December 23, 2015
Study Start
December 1, 2015
Primary Completion
July 1, 2024
Study Completion
July 1, 2024
Last Updated
August 7, 2025
Results First Posted
August 7, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
Data safety and monitoring will be provided by the Hollings Cancer Center DSMC. This committee will serve for all sites. The DSMC meets 6 times a year and reviews all MUSC IRB adverse events, protocol deviations/violations, early stopping rules and internal audit results. The PI will be responsible for identifying, reviewing monthly, and reporting adverse events. Individual participant data will not be shared between the sites. All data will be deidentified and linked with a code.